Stada Group
Wolfgang Rauch possesses extensive experience in procurement and strategic sourcing within the pharmaceutical and healthcare industries. Currently serving as Senior Vice President of Procurement and ESO at STADA Group since September 2023, Wolfgang previously held the position of VP Chief Procurement Officer at Stryker from July 2019 to May 2022. Wolfgang's career includes significant roles at Novartis, where tenure spanned from November 2013 to March 2019 as Chief Procurement Officer, and from September 2005 to October 2013 in various procurement leadership capacities. Prior experience includes pivotal positions with Aventis, where Wolfgang was Senior Director - Head of Global Purchasing Programs and led Global Purchasing for Drug Innovation and Approval, alongside a foundational role at Hoechst AG as Head of Global Purchasing Direct Materials.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.